Abstract
The prognosis of undifferentiated thyroid cancer is extremely poor, and usual postoperative adjuvant therapies including chemotherapy and radiotherapy are almost ineffective. We have given anticancer drugs to such a patient according to the results of chemosensitivity test (SDI method) using highly purified (90%) tumor cells. A 73-year-old woman was admitted to the hospital because of a tumor on the right side of the neck. With a diagnosis of undifferentiated thyroid cancer based on a biopsy, a complete thyroidectomy and lymph nodes dissection were performed. Further extensive surgery was employed for a recurrence. From the excised material, tumor cells were purified up to 90%, for which SDI method was conducted. CDDP and ADM showed higher inhibition rates than other chemotherapeutics. Therefore, intravenous administration of 60mg/m2 of CDDP on the day 1 followed by 40mg/m2 of ADM on the day 4 was designated as one course; and four courses a month were given to the patient for three months. The patient survived for 11 months af-ter the initial operation.It is suggested that appropriate chemotherapeutics selected according to the results of chemosensitivity testing may contribute to improve the prognosis of patients with undifferentiated thyroid cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
